Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Plos One|May 14, 2013
Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's diseaseFrank M Schmidt, Juergen Kratzsch, Hermann-Josef Gertz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 9, 2013
PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brainsGeorg A Becker, Masanori Ichise, Henryk Barthel, et al.
The Lancet. Neurology|April 13, 2011
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic studyHenryk Barthel, Hermann-Josef Gertz, Stefan Dresel, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MRSolveig Tiepolt, Andreas Schäfer, Michael Rullmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2015
Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET ScansMichael Rullmann, Juergen Dukart, Karl-Titus Hoffmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2017
Feasibility of in vivo <sup>18</sup>F-florbetaben PET/MR imaging of human carotid amyloid-βJan Bucerius, Henryk Barthel, Solveig Tiepolt, et al.
Current Alzheimer Research|May 20, 2011
Left anterior temporal lobe sustains naming in Alzheimer's dementia and mild cognitive impairmentLars Frings, Stefan Klöppel, Stefan Teipel, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 13, 2011
Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizesStefan J Teipel, Oliver Peters, Isabella Heuser, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's DiseaseLisa Florek, Solveig Tiepolt, Matthias L Schroeter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 7, 2011
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controlsHenryk Barthel, Julia Luthardt, Georg Becker, et al.
Pageof 6